Medical network May 10 -, head of the administration of state food and drug supervision and administration of the 9th in response to the problem of proprietary Chinese medicine name, specification proprietary Chinese medicine naming and protect the old brand. 

 

In January 2017, the administration of drug safety, issued the proprietary Chinese medicine generically named technology guidelines (draft) ", put forward when naming to insist on the principle of "avoid hinted, exaggerated effect". 

 

Draft, avoid using may give patients in order to imply the pharmacology, anatomy, physiology, pathology or treatment to learn the names of the pharmaceuticals. 

 

The name contains the words "sugar, blood pressure, lipid, anti-inflammatory, cancer". Exaggerated, self-styled, impractical words should not be used. Such as: "treasure" "spirit" "essence" "strong" "quick effect" etc. The name contains the words "imperial" and "secret". 

 

According to the above requirements, some familiar proprietary Chinese medicine may be about to change name, it is thought that for some traditional brand of proprietary Chinese medicine, or because of the name damage its reputation and market. 

 

, held on May 9th "brand, Chinese media exchange meetings" on, eat the drug safety administration of the head, said the current name exists some proprietary Chinese medicine, suggest that curative effect, misleading, standardize the naming of proprietary Chinese medicine, and to protect the old brand contradiction, its foothold is to standardize and promote the healthy development of proprietary Chinese medicine under the new historical conditions. 

 

The chief says, draft will be amended after end for advice, for naming non-standard conditions, effect of exaggerated, language vulgar name of proprietary Chinese medicine, combined with standard promote measures to gradually standardized, such as register again to is really necessary to modify the name of the, will also offer certain time period to gradually transition.